echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Stamp the cells and track in real time what the memory cells do after vaccination?

    Stamp the cells and track in real time what the memory cells do after vaccination?

    • Last Update: 2022-11-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
      

    The magic of vaccines is that they effectively create long-lived immune cells, often for decades
    .
    These immune cells create a protective barrier that prevents or reduces reinfection, as well as a memory that allows us to recognize old invaders like viruses and kill
    them before it causes disease.
    The antibodies in our blood that act as a barrier are produced by "long-lived plasma cells," and while the importance of these cells has long been known, how and when they are produced after vaccination remains a mystery
    .

    Until now, a research team led by Dr Marcus Robinson and Professor David Tarlinton from Monash University's Immune Memory Laboratory, published an article in the prestigious journal Science Immunology, showing in real time how immune memory cells are stored in the bone marrow at a rate of about one cell per hour in
    the weeks following immunization.
    The researchers used the mice's genetic system to map the gradual accumulation
    of these cells.
    This system, called timestamping, allows researchers to indelibly label all plasma cells for a specific period of time after vaccination and then return later to identify those that survived and therefore lived longer
    .
    By performing this test regularly after vaccination, the researchers revealed the history of accumulation of these long-lived cells, pinpointing exactly when and where
    they were born.

    After receiving the vaccination, we still have a great deal of immunity to the disease because our body continues to supply antibodies against this immune disease – basically making sure that the antibodies in our body remain adequate
    .
    While we already know where these long-lived plasma cells are produced in the body, including the lymph nodes, tonsils and intestines, it's not known
    exactly what makes some vaccines keep these cells for decades and disappear after a few months.
    Given the global interest in the long-term immunity provided by COVID vaccines, understanding this process becomes even more urgent
    .
    A mouse model
    using fluorescent proteins (called TdTomato proteins) expressed only in cells that produce antibodies to a specific vaccine was used.
    Because these cells fluoresce, it is possible to track where individual cells are produced and stored
    .

    The study used a range of tools to identify those plasma cells
    produced by vaccines.
    All the plasma cells in the mouse model expressed a fluorescent protein called the TdTomato protein, in which they identified the cells that recognized the vaccine, and finally, by timestamping, they knew when the cells were produced and thus their age
    .

    Studying the process by which these individual cells are born, matured, and stored to protect us from repeated invasions by specific viruses or bacteria "can help us understand how long-lived plasma cells recruit.
    "

    The complexity of this study allowed the researchers to identify other aspects of specific immune establishment:

    • How these plasma cells enter the bone marrow

    • When these plasma cells are stored in areas such as bone marrow, do they necessarily replace other cells?

    • Or the cells "found" a niche vacated by the previous plasma cell death or migration elsewhere

    Mapping of the cells shows that after a mouse was vaccinated with a specific vaccine, about 40,000 persistently present plasma cells
    were produced in the bone marrow.
    After the initial flourishing, these cells decay at a rate of about 0.
    1% per day and have a half-life of about 700 days, which provides both an estimate of the duration of protection and an identification
    for further study of the long-lived cells themselves.

    Professor Tarlinton said understanding how these long-lived plasma cells are produced, survived and died "will help us regulate their recruitment through different vaccine combinations or delivery strategies, ultimately allowing us to extend the lifespan
    of immunity.
    " In fact, the journal Nature recently reported on an exciting work describing how changing the vaccination mechanism can significantly affect the characteristics of the immune response, and we will predict the production of these specialized cells, which has been the focus of
    our work.

    Long-lived plasma cells accumulate in the bone marrow at a constant rate from early in an immune response.

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.